Overexpression of SHANK2 relates to tumor malignant potential and outcomes of gastric cancer.

被引：0
|
作者：
Arakawa, Hiroshi [1 ]
Komatsu, Shuhei [1 ]
Kamiya, Hajime [1 ]
Hamada, Satoshi [1 ]
Yamauchi, Masateru [1 ]
Ishida, Ryo [1 ]
Nishibeppu, Keiji [1 ]
Kiuchi, Jun [1 ]
Imamura, Taisuke [1 ]
Konishi, Hirotaka [1 ]
Shiozaki, Atsushi [1 ]
Kubota, Takeshi [1 ]
Fujiwara, Hitoshi [1 ]
Tsuda, Hitoshi [2 ]
Otsuji, Eigo [1 ]
机构：
[1] Kyoto Pref Univ Med, Div Digest Surg, Kyoto, Japan
[2] Natl Def Med Coll, Invest Pathol, Tokorozawa, Saitama, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1013
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [31] ANO1 and SHANK2 mRNA expression are associated with nodal metastases in oral cancer patients
    Nunes, F.
    Rocha, L. A.
    Tajara, E. H.
    VIRCHOWS ARCHIV, 2015, 467 : S86 - S87
  • [32] Tumor mutational burden as a potential predictive marker for the efficacy of immunotherapy in advanced gastric cancer.
    Jang, Jae Yeon
    Jeong, Sun Young
    Kim, Seung Tae
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 324 - 324
  • [33] Overexpression of YEATS4 contributes to malignant outcomes in gastric carcinoma
    Kiuchi, Jun
    Komatsu, Shuhei
    Imamura, Taisuke
    Nishibeppu, Keiji
    Shoda, Katsutoshi
    Arita, Tomohiro
    Kosuga, Toshiyuki
    Konishi, Hirotaka
    Shiozaki, Atsushi
    Kubota, Takeshi
    Okamoto, Kazuma
    Fujiwara, Hitoshi
    Ichikawa, Daisuke
    Tsuda, Hitoshi
    Otsuji, Eigo
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (12): : 2436 - +
  • [34] Overexpression of cyclooxygenase-2 is associated with tumor angiogenesis in human gastric cancer
    Leung, WK
    To, KF
    Go, MYY
    Ng, EKW
    Chung, S
    Sung, JJY
    GASTROENTEROLOGY, 2002, 122 (04) : A233 - A233
  • [35] Overexpression of GLOI Promotes Tumor Invasion in Gastric Cancer
    Wang, Chia-Siu
    Lin, Kwang-Huei
    GASTROENTEROLOGY, 2011, 140 (05) : S1046 - S1046
  • [36] Analysis of pO2 in malignant ascites of patients with peritoneal dissemination of gastric cancer.
    Emoto, S.
    Kitayama, J.
    Ishigami, H.
    Yamaguchi, H.
    Yamashita, H.
    Kaisaki, S.
    Nagawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [37] Knockdown of KREMEN2 inhibits tumor proliferation and metastasis in gastric cancer.
    Chen, Beibei
    Wang, Saiqi
    Huang, Jinxi
    Li, Jitian
    Zhang, Jianying
    Xu, Weifeng
    Lv, Huifang
    Nie, Caiyun
    Wang, Jianzheng
    Liu, Yingjun
    Chen, Xiaobing
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Circulating tumor DNA dynamics in resectable gastric cancer.
    Leal, Alessandro
    van Grieken, Nicole C. T.
    Phallen, Jillian
    Palsgrove, Doreen N.
    Adleff, Vilmos
    Warmerdam, Fabienne
    Van der Peet, Donald L.
    Verheul, Henk M. W.
    Van Spronsen, D. J.
    Van Riel, Johanna M. G.
    Geenen, Maud
    Portielje, Johanna Elisabeth A.
    Van Laarhoven, Hanneke W. M.
    Jansen, Edwin P. M.
    Sikorska, Karolina
    Kranenbarg, Elma Meershoek-Klein
    Van De Velde, Cornelis J. H.
    Verheij, Marcel
    Cats, Annemieke
    Velculescu, Victor E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] A novel candidate tumor suppressor and a potential prognostic biomarker, hVPS52, in gastric cancer.
    Zhang, Jian
    Hu, Xi-Chun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Ossified uncertain malignant potential gastric glomus tumor with tumor thrombus
    Guvendir, Irem
    Zemheri, Itir Ebru
    Altundal, Kamile
    Ozdil, Kamil
    Kahraman, Resul
    Tosun, Ilkay
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2021, 64 (02) : 369 - 372
12345